AR086791A1 - Moduladores alostericos positivos del receptor de acetilcolina nicotinico - Google Patents

Moduladores alostericos positivos del receptor de acetilcolina nicotinico

Info

Publication number
AR086791A1
AR086791A1 ARP120102330A ARP120102330A AR086791A1 AR 086791 A1 AR086791 A1 AR 086791A1 AR P120102330 A ARP120102330 A AR P120102330A AR P120102330 A ARP120102330 A AR P120102330A AR 086791 A1 AR086791 A1 AR 086791A1
Authority
AR
Argentina
Prior art keywords
alkyl
compounds
alkynyl
cyano
alkenyl
Prior art date
Application number
ARP120102330A
Other languages
English (en)
Spanish (es)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR086791A1 publication Critical patent/AR086791A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP120102330A 2011-07-01 2012-06-28 Moduladores alostericos positivos del receptor de acetilcolina nicotinico AR086791A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201100498 2011-07-01
DKPA201100514 2011-07-05

Publications (1)

Publication Number Publication Date
AR086791A1 true AR086791A1 (es) 2014-01-22

Family

ID=46456582

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120102330A AR086791A1 (es) 2011-07-01 2012-06-28 Moduladores alostericos positivos del receptor de acetilcolina nicotinico

Country Status (3)

Country Link
AR (1) AR086791A1 (fr)
TW (1) TW201315731A (fr)
WO (1) WO2013004617A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102614279B1 (ko) * 2015-08-19 2023-12-18 아스텔라스세이야쿠 가부시키가이샤 테트라히드로옥세피노피리딘 화합물
JP2019006680A (ja) * 2015-11-13 2019-01-17 国立大学法人大阪大学 ピラゾロピリジン誘導体およびその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903997D0 (sv) 1999-11-03 1999-11-03 Astra Ab New compounds
CN101312968A (zh) * 2005-09-23 2008-11-26 记忆药物公司 吲唑、苯并噻唑、苯并异噻唑、苯并异噁唑、吡唑并吡啶、异噻唑并吡啶及其制备和用途
KR20100124272A (ko) 2008-02-07 2010-11-26 아보트 러보러터리즈 양성 알로스테릭 조절제로서의 아미드 유도체 및 이의 사용방법

Also Published As

Publication number Publication date
WO2013004617A1 (fr) 2013-01-10
TW201315731A (zh) 2013-04-16

Similar Documents

Publication Publication Date Title
CO7310522A2 (es) Compuestos de bis (fluoroalquil)-1,4-benzodiazepinona como inhibidores de notch
DOP2015000158A (es) Inhibidores de prmt5 y sus usos
AR100810A1 (es) Inhibidores de fosfatidilinositol 3-quinasa
CO6210729A2 (es) Derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona procedimientos para su preparacion y su uso como agente farmaceutico
PE20190446A1 (es) Moduladores alostericos positivos del receptor muscarinico de acetilcolina m4
PE20180318A1 (es) Procedimiento para preparar isoquinolinonas y formas solidas de isoquinolinonas
EA201890152A1 (ru) Производные 2,3-дигидро-4h-1,3-бензоксазин-4-онов в качестве модуляторов холинергического мускаринового m1 рецептора
AR092108A1 (es) Piridazina 1,4 disustituida, analogos de la misma y metodos para tratar las enfermedades relacionadas con deficiencia del smn
ECSP15012804A (es) Alcoxipirazoles como activadores de guanilato ciclasa soluble
AR087915A1 (es) N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la bace1
AR092319A1 (es) Carbazoles que contienen sulfonamidas como moduladores de criptocromo
AR082111A1 (es) Furopiridinas o tienopiridinas condensadas, composiciones farmaceuticas que las contienen utiles para tratar trastornos psicoticos y del sistema nervioso central, y metodo de preparacion de las mismas
AR100806A1 (es) Inhibidores de fosfatidilinositol 3-quinasa
DOP2015000002A (es) Derivados de azaindol que actuan como inhibidores de p13k
AR090293A1 (es) Inhibidores de quinasa a base de arileter
CR20140133A (es) Compuestos de piridazinona y sus usos como inhibidores de daao
AR100713A1 (es) Derivados de amida de compuestos de 1-oxa-4,9-diazaespiro undeceno que tienen actividad multimodal contra el dolor
AR100715A1 (es) Derivados de alquilo de compuestos 1-oxa-4,9-diazaespiro undeceno que tienen actividad multimodal contra el dolor
AR105522A1 (es) Derivados de amida sustituida que tienen actividad multimodal contra el dolor
PE20150289A1 (es) Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos
CO2019001181A2 (es) Compuestos de heteroarilcarboxamida como inhibidores de ripk2
AR116424A1 (es) Moduladores de la somatostatina y usos de los mismos
AR083694A1 (es) USO DE COMPUESTOS FARMACEUTICOS ACTIVOS PARA EL TRATAMIENTO DE ESTADOS PATOLOGICOS DEL SISTEMA NERVIOSO CENTRAL, COMPOSICION FARMACEUTICA, MODULADOR ALOSTERICO NEGATIVO DEL GABA A a5, METODO
UY35551A (es) Derivados heteroarilos como inhibidores de aldosterona sintasa
AR072803A1 (es) Tetrahidrocinolinas como inhibidores de la 11- beta -hsd1 para la diabetes

Legal Events

Date Code Title Description
FA Abandonment or withdrawal